Inventory Summary of Adimmune Corporation

Adimmune Corporation's latest annual inventory in 2023 was 526.4 Million TWD , down -20.16% from previous year.
Adimmune Corporation's latest quarterly inventory in 2024 Q1 was 777.82 Million TWD , up 47.76% from previous quarter.
Adimmune Corporation reported annual inventory of 659.32 Million TWD in 2022, up 30.33% from previous year.
Adimmune Corporation reported annual inventory of 505.87 Million TWD in 2021, up 67.48% from previous year.
Adimmune Corporation reported quarterly inventory of 777.82 Million TWD for 2024 Q1, up 47.76% from previous quarter.
Adimmune Corporation reported quarterly inventory of 945.51 Million TWD for 2023 Q2, up 23.66% from previous quarter.

Annual Inventory Chart of Adimmune Corporation (2023 - 2009)

Historical Annual Inventory of Adimmune Corporation (2023 - 2009)

Year	Inventory	Inventory Growth
2023	526.4 Million TWD	-20.16%
2022	659.32 Million TWD	30.33%
2021	505.87 Million TWD	67.48%
2020	302.04 Million TWD	-29.41%
2019	427.89 Million TWD	-12.79%
2018	490.62 Million TWD	-23.09%
2017	637.93 Million TWD	25.59%
2016	507.95 Million TWD	2.87%
2015	493.8 Million TWD	32.7%
2014	372.12 Million TWD	21.86%
2013	305.38 Million TWD	81.82%
2012	167.96 Million TWD	-11.24%
2011	189.23 Million TWD	-23.61%
2010	247.72 Million TWD	-5.6%
2009	262.4 Million TWD	0.0%

Year	Inventory	Inventory Growth
2024 Q2	1.01 Billion TWD	23.73%
2024 Q1	777.82 Million TWD	47.76%
2023 Q2	945.51 Million TWD	23.66%
2023 Q4	526.4 Million TWD	-31.24%
2023 Q1	764.62 Million TWD	15.97%
2023 FY	526.4 Million TWD	-20.16%
2023 Q3	765.55 Million TWD	-19.03%
2022 Q3	741.46 Million TWD	-13.55%
2022 FY	659.32 Million TWD	30.33%
2022 Q1	606.1 Million TWD	19.81%
2022 Q2	857.69 Million TWD	41.51%
2022 Q4	659.32 Million TWD	-11.08%
2021 FY	505.87 Million TWD	67.48%
2021 Q3	785.53 Million TWD	8.04%
2021 Q4	505.87 Million TWD	-35.6%
2021 Q2	727.06 Million TWD	74.53%
2021 Q1	416.59 Million TWD	37.92%
2020 Q2	640.66 Million TWD	88.1%
2020 Q3	623.04 Million TWD	-2.75%
2020 Q4	302.04 Million TWD	-51.52%
2020 FY	302.04 Million TWD	-29.41%
2020 Q1	340.6 Million TWD	-20.4%
2019 Q1	523.78 Million TWD	6.76%
2019 Q2	768.7 Million TWD	46.76%
2019 Q3	780.65 Million TWD	1.55%
2019 FY	427.89 Million TWD	-12.79%
2019 Q4	427.89 Million TWD	-45.19%
2018 Q4	490.62 Million TWD	-49.83%
2018 FY	490.62 Million TWD	-23.09%
2018 Q1	691.17 Million TWD	8.35%
2018 Q2	926.32 Million TWD	34.02%
2018 Q3	977.97 Million TWD	5.58%
2017 Q2	747.08 Million TWD	33.5%
2017 Q1	559.61 Million TWD	10.17%
2017 FY	637.93 Million TWD	25.59%
2017 Q4	637.93 Million TWD	-11.56%
2017 Q3	721.32 Million TWD	-3.45%
2016 FY	507.95 Million TWD	2.87%
2016 Q4	507.95 Million TWD	-29.47%
2016 Q3	720.18 Million TWD	8.27%
2016 Q2	665.17 Million TWD	22.48%
2016 Q1	543.07 Million TWD	9.98%
2015 Q2	665.56 Million TWD	43.31%
2015 Q3	624.11 Million TWD	-6.23%
2015 FY	493.8 Million TWD	32.7%
2015 Q4	493.8 Million TWD	-20.88%
2015 Q1	464.41 Million TWD	24.8%
2014 Q1	422.55 Million TWD	38.37%
2014 FY	372.12 Million TWD	21.86%
2014 Q4	372.12 Million TWD	-27.66%
2014 Q2	484 Million TWD	14.54%
2014 Q3	514.43 Million TWD	6.29%
2013 Q2	325.62 Million TWD	35.77%
2013 Q4	305.38 Million TWD	-26.66%
2013 FY	305.38 Million TWD	81.82%
2013 Q1	239.84 Million TWD	42.8%
2013 Q3	416.36 Million TWD	27.87%
2012 Q4	167.96 Million TWD	-39.59%
2012 Q3	278.02 Million TWD	39.68%
2012 Q1	163.95 Million TWD	-13.36%
2012 FY	167.96 Million TWD	-11.24%
2012 Q2	199.04 Million TWD	21.4%
2011 Q4	189.23 Million TWD	-35.23%
2011 Q2	247.67 Million TWD	0.0%
2011 Q3	292.19 Million TWD	17.98%
2011 FY	189.23 Million TWD	-23.61%
2010 FY	247.72 Million TWD	-5.6%
2010 Q4	247.72 Million TWD	0.0%
2009 FY	262.4 Million TWD	0.0%

Peer Inventory Comparison of Adimmune Corporation

Name	Inventory	Inventory Difference
Apex Biotechnology Corp.	747.71 Million TWD	29.598%
Sinphar Pharmaceutical Co.,Ltd.	839.19 Million TWD	37.272%
Panion & Bf Biotech Inc.	538.09 Million TWD	2.173%
Chunghwa Chemical Synthesis & Biotech Co., Ltd.	1.21 Billion TWD	56.532%
GenMont Biotech Incorporation	88.11 Million TWD	-497.388%
Abnova (Taiwan) Corporation	408.3 Million TWD	-28.926%
Tanvex BioPharma, Inc.	108.28 Million TWD	-386.13%
Polaris Group	36.35 Million TWD	-1347.96%
Energenesis Biomedical CO.,LTD.	733 Thousand TWD	-71715.28%
UnicoCell Biomed Co., Ltd.	5.45 Million TWD	-9557.054%
PELL Bio-Med Technology Co. Ltd.	3.76 Million TWD	-13888.998%

Global Stocks Search

Adimmune Corporation (4142.TW)

Inventory Summary of Adimmune Corporation

Annual Inventory Chart of Adimmune Corporation (2023 - 2009)

Historical Annual Inventory of Adimmune Corporation (2023 - 2009)

Peer Inventory Comparison of Adimmune Corporation